Variations of ATP and Its Metabolites in the Hippocampus of Rats Subjected to Pilocarpine-induced Temporal Lobe Epilepsy
Overview
Authors
Affiliations
Although purinergic receptor activity has lately been associated with epilepsy, little is known about the exact role of purines in epileptogenesis. We have used a rat model of temporal lobe epilepsy induced by pilocarpine to study the dynamics of purine metabolism in the hippocampus during different times of status epilepticus (SE) and the chronic phase. Concentrations of adenosine 5'-triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), and adenosine in normal and epileptic rat hippocampus were determined by microdialysis in combination with high-performance liquid chromatography (HPLC). Extracellular ATP concentrations did not vary along 4 h of SE onset. However, AMP concentration was elevated during the second hour, whereas ADP and adenosine concentrations augmented during the third and fourth hour following SE. During chronic phase, extracellular ATP, ADP, AMP, and adenosine concentrations decreased, although these levels again increased significantly during spontaneous seizures. These results suggest that the increased turnover of ATP during the acute period is a compensatory mechanism able to reduce the excitatory role of ATP. Increased adenosine levels following 4 h of SE may contribute to block seizures. On the other hand, the reduction of purine levels in the hippocampus of chronic epileptic rats may result from metabolic changes and be part of the mechanisms involved in the onset of spontaneous seizures. This work provides further insights into purinergic signaling during establishment and chronic phase of epilepsy.
Pannexin1 Mediates Early-Life Seizure-Induced Social Behavior Deficits.
Obot P, Cibelli A, Pan J, Velisek L, Veliskova J, Scemes E ASN Neuro. 2024; 16(1):2371164.
PMID: 39024558 PMC: 11262470. DOI: 10.1080/17590914.2024.2371164.
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy.
Thakku Sivakumar D, Jain K, Alfehaid N, Wang Y, Teng X, Fischer W Int J Mol Sci. 2024; 25(13).
PMID: 39000004 PMC: 11241490. DOI: 10.3390/ijms25136894.
Liang Y, Zhao L, Dai C, Liu G, Zhong Y, Liu H Mol Neurobiol. 2023; 60(11):6627-6641.
PMID: 37468739 DOI: 10.1007/s12035-023-03508-3.
Zhou B, Fan K, Guo J, Feng J, Yang C, Li Y Sci Adv. 2023; 9(22):eadg0218.
PMID: 37267364 PMC: 10413668. DOI: 10.1126/sciadv.adg0218.
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy.
Engel T Int J Mol Sci. 2023; 24(6).
PMID: 36982485 PMC: 10049244. DOI: 10.3390/ijms24065410.